VIVLI, the Center for Global Clinical Research, is seeking a Clinical Trial Disclosure Specialist. Vivli is a mission-focused non-profit and to help manage our continued growth, we are looking for a detail-oriented Clinical Trial Disclosure Specialist to join the operations team. The operations team manages the governance process to help researchers seeking to access to datasets from contributors.
Location: Remote, working core hours of 9am-5pm Eastern timezone.
Responsibilities will include, but not limited to:
- Manage day-to-day data request review process for specific requests following strict SOPs.
- Work closely with Vivli end users to ensure researchers and members meet assigned requirements on specific requests.
- Support researchers with enquiries and related requests and follow ups.
- Manage and help contribute to projects related to Vivli’s mission.
- Contribute to process improvements to make the data request process more efficient for researchers and data contributors.
- Perform other duties when requested.
Qualifications
- Minimum 2 years prior experience managing data disclosure processes, either at an existing repository, platform or as a data contributor
- Understanding of global regulatory requirements for clinical trial disclosure, preferred
- 2 years of experience working in an academic medical center, industry or government preferred
- Excellent written and oral communication skills and interpersonal skills
- 2-3 years of prior experience with following agreed SOPs and process improvement
- Computer proficiency in MS Office, Excel, PowerPoint, Dropbox etc.
- Excellent organizational skills and high attention to detail and accuracy
- Ability to manage projects and resources
- Bachelor’s degree in the health profession or science field.
What We Offer
- Comprehensive benefits package, including health, dental, and vision insurance.
- Opportunities for professional growth and development
- Flexible work arrangements
- A dynamic and collaborative workplace culture
- Meaningful work that makes a real difference in the world
How to Apply
Must be authorized to work in the US. Interested candidates should submit their resume and a cover letter to hr@vivli.org
Rheumatoid arthritis (RA) is an autoimmune disorder, which primarily affects the joints and is characterized by inflammation and pain. RA most commonly affects the hands and wrists, but can also affect other parts of the body. There is currently no cure for RA, but treatment options have improved considerably in recent years with the development of new therapies and treatment strategies.
Rheumatoid arthritis (RA) poses a significant challenge due to its chronic nature and impact on joint health. While treatments have evolved, achieving remission remains elusive for many patients. Using a dataset from the Vivli repository, Dr. Ricardo Ferreira and a team of researchers delved into examining the assessment criteria for remission in RA, shedding light on the limitations of current approaches and proposing a new model—the dual target strategy.
In a recent study led by Dr. Sarah Nevitt, a senior research associate at the University of Liverpool, a team of researchers examined the effectiveness of various antiepileptic drugs (AEDs) used as monotherapy for people experiencing seizures due to epilepsy. Epilepsy, a common neurological disorder, results from abnormal electrical discharges in the brain, causing recurrent seizures. Typically, around 60% to 70% of individuals with epilepsy achieve longer-term remission, often shortly after beginning treatment with antiepileptic drugs.